2009 Georg Charles de Hevesy Nuclear Pioneer Award Goes to Trio of Cardiolite/Sestamibi Developers: Alan Davison, Ph.D.; Alun G. Jones, Ph.D.; and Michael J. Abrams, Ph.D.
TORONTO-Millions of heart attack patients and other potential sufferers who have undergone a noninvasive nuclear imaging test with the isotope technetium-99 can thank three innovators-Alan Davison, Ph.D.; Alun G. Jones, Ph.D.; and Michael J. Abrams, Ph.D.-all of whom received SNM's 2009 Georg Charles de Hevesy Nuclear Pioneer Award.
Davison, professor emeritus of chemistry at Massachusetts Institute of Technology, Cambridge, Mass., and Jones, a professor of radiology at Harvard Medical School and the Brigham and Women's Hospital, Boston, Mass., began a systematic exploration of the basic chemistry of technetium in 1976.
Jones, an SNM member, is currently director of the radiopharmaceutical chemistry section at Harvard Medical School's Laboratory for Experimental Nuclear Medicine.
He received his doctorate in nuclear chemistry from the University of Liverpool and, following postdoctoral positions in Amsterdam and then MIT, joined Harvard in 1971.
has more than 200 publications, and his
research interests continue to be in the development of new radiodiagnostic agents and novel applications of radioactive compounds to medical problems.
In 1993, Davison and Jones
shared SNM's Paul C. Aebersold Award for Outstanding Achievement in Basic Science Applied to Nuclear Medicine.